Characteristics of five human tumor cell lines and sublines resistant to cis‐diamminedichloroplatinum(II)

International Journal of Cancer

Volumn 47, Issue 2, 1991, Pages 252-260

  Teicher, Beverly A ^a,b   Holden, Sylvia A ^a   Herman, Terence S ^a,b   Sotomayor, Enrique Alvarez ^a   Khandekar, Vrinda ^a   Rosbe, Kristina W ^a   Brann, Terrence W ^a   Korbut, Timothy T ^a   Iii, Emil Frei ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYCYCLOPHOSPHAMIDE; 4 HYDROXYIFOSFAMIDE; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE; MELPHALAN; METHOTREXATE; MITOMYCIN C; TETRAPLATIN; THIOTEPA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; TUMOR CELL LINE;

ADENOCARCINOMA; BREAST NEOPLASMS; CARBOPLATIN; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; CISPLATIN; DNA; DRUG RESISTANCE; GLUTATHIONE TRANSFERASE; HUMAN; LUNG NEOPLASMS; MELANOMA; NEOPLASMS; ORGANOPLATINUM COMPOUNDS; PLATINUM; SULFHYDRYL COMPOUNDS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0026029535     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910470214     Document Type: Article

References (71)

1. Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2‐diaminocyclohexane
2. Differential potentiation of alkylating and platinating agent toxicity in human ovarian carcinoma cells by glutathione depletion
3. Characterization of cisplatin‐resistant COLO 316 human ovarian carcinoma cells
4. cis‐Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
5. Resistance against cis‐dichlorodiammineplatinum in cultured cells with a high content of metallothionein
6. Factors influencing the sensitivity of two human bladder carcinoma cell lines to cisdiam‐minedichloroplatinum(II)
7. Studies of cross‐resistant synergistic combinations and blocking of activity of platinum derivatives
8. Preparing nuclei from cells in monolayer cultures suitable for counting and for following synchronized cells through the cell cycle
9. Biotransformations of tetraplatin in rat plasma
10. A fluorometric assay for glutathione
11. High‐performance liquid chromatography determination of platinum(II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrophotometric method
12. Enhanced DNA repair as a mechanism of resistance to cis‐diamminedichloroplatinum(II)
13. Evidence that glutathione may determine the differential cell‐cycle phase toxicity of a platinum(IV) antitumor agent
14. The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro
15. Tissue sulfhydryl groups
16. Tumors from a cell strain with a high content of metallothionein show enhanced resistance against cis‐dichlorodiammineplatinum
17. L‐Dopa decarboxylase activity (DDC): a distinguishing biomarker for the growth of small cell lung cancer (SCCL) in tissue culture
18. Effects of dibutyral cyclic adenosine 3′,5′‐monophosphate on the growth of cultured human small cell lung carcinoma and the specific cellular activity of L‐dopa decarboxylase
19. Alkylating agent resistance: in vitro studies with human cell lines
20. Rapid reduction of tetrachloro‐D L‐trans‐1,2‐diaminocyclohexaneplatinum‐IV tetraplatin in RPMI 1640 tissue culture medium
21. Amino acid membrane transport properties of L1210 cells resistant to cisplatin
22. Assays for differentiation of glutathi‐one‐S‐transferases
23. Glutathione‐S‐transferases
24. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drag‐resistant and ‐sensitive human ovarian carcinoma cell lines by buthionine sulfoxime mediated glutathione depletion
25. 2[tetrachloroplatinum(II)], rhodamine‐123, and potassium tetrachloroplatinum in vitro and in vivo
26. 2 in a human squamous carcinoma cell line and a cis‐diamminedichloroplatinum(II) resistant subline
27. Development of fluorescence between o‐phthaldialdehyde and thiols
28. Overexpression of metallothionein confers resistance to anticancer drugs
29. Activity of tetraplatin isomers against cisplatin sensitive and resistant human tumor cell lines
30. Accumulation of cis‐diamminedichloroplatinum(II) and platinum analogues by platinum‐resistant murine leukemia cells in vitro
31. Transport of cis‐Pt and cis‐Pt analogs in sensitive and resistant murine leukemia cell lines
32. Rapid communications: enhanced DNA repair and resistance to cisplatin in human ovarian cancer
33. Selective toxicity of rhodamine 123 in carcinoma cells in vitro
34. Cisplatin
35. Development of drug resistance in a murine mammary tumor
36. Evaluation of novel platinum II and platinum IV ammine/ amine complexes using L1210 sublines resistant to cisplatin or tetraplatin
37. Molecular mechanisms of resistance of human ovarian cancer cells to cisplatin and tetraplatin
38. Therapeutic and pharmacological studies of tetrachloro(d,l‐trans)1,2‐diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analog
39. Serial cultivation of normal human epidermal kerati‐nocytes
40. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas
41. Fundamental studies with cisplatin
42. III, Collateral methotrexate resistance in cultured human head and neck carcinoma cell selected for resistance to cis‐diamminedichloroplatinum(II)
43. Mechanisms of resistance to cis‐diammine‐dichloroplatinum(II) in a rat ovarian carcinoma cell line
44. Inhibition of amino acid transport by cisplatin and its derivatives in L1210 murine leukemia cells
45. Estimation of total protein‐bound and non‐protein sulfhydryl groups in tissue with Ellman's reagent
46. In vivo resistance towards anthracycline etoposide and cis‐diamminedichloroplatinum(II)
47. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines
48. DNA repair in cells sensitive and resistant to cis‐diamminedichloroplatinurn(II): host cell reactivation of damaged plasmid DNA
49. Properties of amino acid transport systems in K562 cells sensitive and resistant to cis‐diamminedichloroplatinum(II)
50. Comparative toxicity and renal distribution of the platinum analogs tetraplatin, CHIP, and cisplatin at equimolar doses in the Fischer 344 rat
51. In vivo biochemical indexes of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat
52. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells
53. Alkylating agents: in vitro studies of cross‐resistance patterns in human tumor cell lines
54. Development of alkylating agent‐resistant human tumor lines
55. HI, Characterization of a human squamous carcinoma cell line resistant to cis‐diam‐minedichloroplatinum(II)
56. Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo
57. 2 with superhelical DNA and with radiation in vitro and in vivo
58. 2: DNA interaction, cytotoxicity and radiosensitization
59. 2 with hyperthermia
60. Interactions of the carcinogen 4‐nitroquinoline 1‐oxide with the nonprotein thiols of mammalian cells
61. Changes in calcium channel activity in membranes from cis‐diamminedichloroplatinum(II)‐resistant and ‐sensitive L1210 cells
62. Hyperthermic potentiation of cis‐diamminedichloroplatinum(II) cytotoxicity in Chinese hamster ovary cells resistant to the drug
63. Cross‐resistance and glutathione‐S‐transferase‐π levels among four human melanoma cell lines selected for alkylating agent resistance
64. Biochemical studies on resistance to cw‐platinum (cis‐DDP) in L1210 leukemia
65. Differential uptake of cis‐diamminedichloroplatinum(II) by sensitive and resistant murine L1210 leukemia cells
66. 3,4‐Dihydrobenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma
67. Evaluation of trans‐tetrachloro‐1,2‐diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis‐diamminedichloroplatinum(II)
68. A comparison of radiation‐sensitizing ability and cell uptake for NDPP and Ro‐07‐0582
69. DNA‐protein and interstrand cross‐linking by cis‐ and trans‐platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity
70. Kinetics of formation and disappearance of a DNA cross‐linking effect in mouse leukemia L1210 cells treated with cis‐ and trans‐diamminedichloroplatinum(II)